NationalSerum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For AdultsBY PTI
NationalSerum Institute's Vaccine Against Cervical Cancer To Be Available In Market This Month, Priced At Rs 2000 For Two DosesBY PTI
NationalGovt Likely To Float Global Tender For HPV Vaccine In April; Merck, Serum Institute May ParticipateBY PTI
NationalSerum Institute Seeks Drug Regulator's Approval For Market Authorisation Of Its Covid Vaccine As Booster DoseBY PTI
NationalSII Seeks Govt's Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical CancerBY Outlook Web Desk
NationalNTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And AboveBY Outlook Web Desk
NationalSerum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis VaccineBY Outlook Web Desk
NationalSII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In AdultsBY Outlook Web Desk
NationalCovovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SIIBY Outlook Web Desk
NationalCDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine CovovaxBY Outlook Web Desk
NationalSerum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar PoonawallaBY Outlook Web Desk
NationalCovishield Gets Australian Medicine Regulator's Approval For Incoming TravellersBY Outlook Web Desk
NationalCentre To Receive 20 Crores Of Covishield Doses From Serum Institute In SeptemberBY Outlook Web Desk
NationalCentre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector QuotaBY Outlook Web Bureau
NationalSerum Institute Chairman Praises Modi Govt For Controlling Red-Tapism And Licence RajBY Outlook Web Desk
National‘It May Start Blame Game’: Serum Institute’s Cyrus Poonawalla Against Mixing Covid VaccinesBY Outlook Web Bureau
NationalRevised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health MinisterBY Outlook Web Desk
NationalGovt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health MinisterBY Outlook Web Desk
Making A DifferenceNot Received Marketing Authorisation Application For Covishield: EU Medical BodyBY Outlook Web Bureau
NationalConfident That European Union Will Approve Covishield In A Month: Adar PoonawallaBY Outlook Web Bureau
Making A DifferenceNot Received Any Application Seeking Approval For Covishield: European Medicines AgencyBY Outlook Web Bureau
.png?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
_.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
